Patte, C., Auperin, A., Gerrard, M., Michon, J., Pinkerton, R., Sposto, R., . . . Cairo, M. S. (2007). Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: It is possible to reduce treatment for the early responding patients. American Society of Hematology.
Chicago ZitierstilPatte, Catherine, et al. Results of the Randomized International FAB/LMB96 Trial for Intermediate Risk B-cell Non-Hodgkin Lymphoma in Children and Adolescents: It Is Possible to Reduce Treatment for the Early Responding Patients. American Society of Hematology, 2007.
MLA ZitierstilPatte, Catherine, et al. Results of the Randomized International FAB/LMB96 Trial for Intermediate Risk B-cell Non-Hodgkin Lymphoma in Children and Adolescents: It Is Possible to Reduce Treatment for the Early Responding Patients. American Society of Hematology, 2007.